Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2023 Oct 6;10:1272728. doi: 10.3389/fnut.2023.1272728

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2023 Ohara, Suda, Kohya, Sasaki, Yoda, Yoshida, Fu, Yang, Hosoda, Maehara, Ohnishi, Tokuchi, Kitagataya, Kawagishi, Nakai, Sho, Natsuizaka, Ogawa and Sakamoto.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

PMC Copyright notice

Survival rates in patients with and without muscle atrophy Kaplan–Meier estimates of overall survival stratified according to muscle atrophy in patients with HCC. The median overall survival is not reached in patients without muscle atrophy and 3.52 years in patients with muscle atrophy. Patients with muscle atrophy have a poorer prognosis than those without muscle atrophy (log-rank p-value = 0.004; crude Cox regression hazard ratio: 1.88, 95% confidence interval: 1.18–2.99). HCC, hepatocellular carcinoma.

HHS Vulnerability Disclosure